Chemours reported Q2 2024 financial results with net sales of $1.5 billion, a 6% decrease year-over-year. Net income attributable to Chemours was $70 million, or $0.46 per diluted share, compared to a net loss of $376 million in the prior-year quarter. Adjusted EBITDA was $206 million, down from $324 million in the corresponding prior-year quarter.
Net Sales of $1.5 billion, down 6% year-over-year.
Net Income attributable to Chemours of $70 million, or $0.46 per diluted share, compared with a Net Loss attributable to Chemours of $376 million, or $2.52 per diluted share, in the corresponding prior-year quarter
Adjusted Net Income of $57 million, or $0.38 per diluted share, compared with $167 million, or $1.10 per diluted share, in the corresponding prior-year quarter
Received permit to expand Teflon™ PFA resin production under APM Performance Solutions; a critical material for semiconductor manufacturing
The Company anticipates a low to mid-single digit sequential decline in Net Sales for the third quarter.
Visualization of income flow from segment revenue to net income